Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Eisai Inc.
SWOG Cancer Research Network
Takeda
Rigshospitalet, Denmark
Brown University
Barbara Ann Karmanos Cancer Institute
SWOG Cancer Research Network
Checkpoint Therapeutics, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Calithera Biosciences, Inc
Genprex, Inc.
Peking University First Hospital
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
University of Arizona
Peking University First Hospital
Amgen
Stanford University
Boehringer Ingelheim
Sun Yat-sen University
University of Kentucky
National Cancer Institute (NCI)
Eli Lilly and Company